Johnson Matthey (LON:JMAT) Insider Liam Condon Purchases 10,951 Shares of Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon purchased 10,951 shares of the stock in a transaction that occurred on Friday, September 11th. The stock was acquired at an average cost of GBX 2,306 per share, with a total value of £252,530.06.

Liam Condon also recently made the following trade(s):

  • On Friday, July 10th, Liam Condon acquired 14 shares of Johnson Matthey stock. The shares were bought at an average cost of GBX 1,909 per share, for a total transaction of £267.26.

Johnson Matthey Trading Down 1.4%

JMAT stock traded down GBX 31.87 during midday trading on Monday, reaching GBX 2,214. 714,881 shares of the company traded hands, compared to its average volume of 2,051,367. Johnson Matthey PLC has a 52-week low of GBX 2,192 and a 52-week high of GBX 3,245.33. The company has a debt-to-equity ratio of 69.69, a quick ratio of 0.76 and a current ratio of 1.56. The business has a 50 day moving average of GBX 2,112.39 and a 200-day moving average of GBX 2,055.82. The firm has a market capitalization of £2.79 billion, a price-to-earnings ratio of -29.03, a P/E/G ratio of 49,242.50 and a beta of 0.94.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Jefferies Financial Group reissued a “buy” rating and issued a GBX 2,330 target price on shares of Johnson Matthey in a research note on Tuesday, August 4th. UBS Group restated a “neutral” rating and set a GBX 2,200 target price on shares of Johnson Matthey in a research report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a GBX 2,400 target price on shares of Johnson Matthey in a research note on Monday, July 6th. Finally, Berenberg Bank increased their price target on Johnson Matthey from GBX 2,100 to GBX 2,300 and gave the stock a “buy” rating in a report on Monday, June 1st. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 2,283.33.

Read Our Latest Analysis on JMAT

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Featured Stories

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.